분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2017-08-14 16:03:20 , Hit : 892
 full.jpg (21.4 KB), Download : 9
 CRISPR Corrects RNA-based Disease Defects


Muscle cells from a patient with myotonic dystrophy type I, untreated (left) and treated with the RNA-targeting Cas9 system (right). The MBNL1 protein is in green, repetitive RNA in red, and the cell's nucleus in blue.

http://www.the-scientist.com/?articles.view/articleNo/50064/title/CRISPR-Corrects-RNA-based-Disease-Defects/&utm_campaign=NEWSLETTER_TS_The-Scientist-Daily_2016&utm_source=hs_email&utm_medium=email&utm_content=55196861&_hsenc=p2ANqtz-9_YDiUBs86US91j4DInDpaheYvIUjEpFbUfGlafwOelZqs1IEAalr9bCzm0xiDEheVQefwPrQY7FiTvQTLB_WfE43aRA&_hsmi=55196861


The Scientist »
The Nutshell


In human cells, researchers deploy the genome editor to snip out toxic repetitive sequences.

By Kerry Grens | August 10, 2017


UC SAN DIEGO HEALTH
Armed with a modified version of CRISPR-Cas9, scientists have removed nucleotide repeats from RNA in vitro that are known to cause diseases, namely, Huntington’s, ALS, and myotonic dystrophy. Cells from patients with myotonic dystrophy were restored to normal function after the CRISPR treatment, Gene Yeo of the University of California, San Diego, and colleagues report today (August 10) in Cell.

“It’s tempting to imagine how this exciting capability might be used to treat genetic diseases one day, although many additional studies are needed to test this possibility,” Harvard University professor David Liu, who was not part of the study, tells KPBS.

The study is an extension of previous work from Yeo’s lab developing the so-called RCas9 nuclease, which homes in on RNA rather than Cas9’s normal DNA target. The researchers used RCas9 to cut away microsatellite repeat extensions, strings of sequence copies responsible for disease.

See “RNA-Targeting CRISPR”

Lead author and postdoc Ranjan Batra points out the difference between targeting RNA and targeting DNA. “Any changes we make to DNA are permanent,” he tells KPBS. “Any changes that we make to RNA stay for only a few hours until a new RNA is made.”

Yeo tells the San Diego Union Tribune that a viral vector-administered RNA treatment could last 5-10 years. “The main thing we don’t know yet is whether or not the viral vectors that deliver RCas9 to cells would elicit an immune response,” he says in a statement. “Before this could be tested in humans, we would need to test it in animal models, determine potential toxicities and evaluate long-term exposure.”







1207   Cancer Onset May Be Caused by Immune System Fighting Viruses  이성욱 2017/08/25 871
1206   Resistance to HIV Engineered Via CRISPR  이성욱 2017/08/07 878
1205   Zika Update  이성욱 2016/03/15 881
1204   [바이오토픽] 드디어 올 것이 왔다: CRISPR, 생존가능 인간배아의 질병초래 유전자 교정 성공  이성욱 2017/08/03 884
1203   “유전자 치료 법률 금지 한국 유일” vs “생명체 설계도 바꾸는 건 문제”  이성욱 2017/08/28 889
  CRISPR Corrects RNA-based Disease Defects  이성욱 2017/08/14 892
1201   [바이오토픽] 중국, 최초의 유전체편집 아기 탄생  이성욱 2018/11/27 902
1200   CRISPR Fixes Stem Cells Harboring Blindness-Causing Defect  이성욱 2016/02/01 904
1199   First In Vivo Human Genome Editing to Be Tested in New Clinical Trial  이성욱 2017/05/18 908
1198   [바이오토픽] FDA 자문위원회, CAR-T(chimeric antigen receptor T cell) 승인 만장일치로 권고  이성욱 2017/07/14 918
1197   ‘단세포 인공생명체’ 눈앞에 성큼  이성욱 2017/03/11 919
1196   유전자치료제 '인보사' 연골재생 입증못해도 허가받은 까닭  이성욱 2017/07/14 925
1195   CRISPR Can Tag RNA  이성욱 2016/03/26 928
1194   Engineered Human Liver Tissue Grows in Mice  이성욱 2017/07/25 929
1193   Revisiting CAR T-Cells for Treating HIV Shows Promise  이성욱 2016/07/19 931
1192   독감바이러스의 ‘RNA 도둑질’  이성욱 2017/05/08 931
1191   RNA May Surpass DNA in Precision Medicine  이성욱 2016/03/23 936
1190   UPDATE 2-Gilead experimental drug fights all forms of hep C: data  이성욱 2015/09/24 938
1189   노벨 생리의학상 유감(有感)  이성욱 2015/10/06 938
1188   Editas Expands CRISPR Capabilities through New Technology Licensing  이성욱 2016/12/22 938

[1][2][3] 4 [5][6][7][8][9][10]..[64] [다음 10개]
 

Copyright 1999-2024 Zeroboard / skin by ROBIN